Description
This test evaluates how well a patient responds to the antiplatelet medication clopidogrel (Plavix). Clopidogrel is commonly prescribed to prevent blood clots in patients with certain cardiovascular conditions. Some individuals may have genetic variations that affect their response to the drug, making it less effective. The test helps identify these “poor metabolizers” who might need alternative or adjusted antiplatelet therapy. Results can guide healthcare providers in personalizing treatment plans, potentially reducing the risk of adverse cardiovascular events or unnecessary bleeding complications.
Reviews
There are no reviews yet.